Babcock & Wilcox (NYSE: BW) reported Q4 EPS of $0.47, $0.04 better than the analyst estimate of $0.43. Revenue for the quarter came in at $502.7 million versus the consensus estimate of $452.8 million.

Our Board of Directors previously authorized the repurchase of up to $100 million of common stock. An initial buyback program combined with share repurchases to off-set dilution will use approximately $53 million of the current authorization no later than the end of the first quarter 2016.

For earnings history and earnings-related data on Babcock & Wilcox (BW) click here.